Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite antagonistic effects in heart contraction is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
French National Research Agency (ANR)
Grant: ANR-21-CE11-0022
Targeting Myosin : understanding and tuning force production for therapy development
French National Research Agency (ANR)
Grant: ANR-10-IDEX-0001
National Institutes of Health
Grant: 5RM1GM131981-03
From proteins to cells to tissues: A multi-scale assessment of biomechanical regulation by the myosin molecular motor
Fields of Study
Keywords